RBx-7796 (sodium)
RBx-7796 (sodium) is a competitive, highly selective, orally active 5-LO (IC50 = 3.5 mM for human 5-LO enzyme) inhibitor. RBx-7796 (sodium) can effectively inhibit 5-LO activity and LTB4 release. RBx-7796 (sodium) can significantly inhibit airway inflammation and bronchial constriction[1].
Product Specifications
CAS Number
794528-96-4
UNSPSC
12352005
Target
Lipoxygenase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Smiles
O=C(O[Na])CC(C=C1)=CC=C1NC(N[C@H]([C@]2([H])[C@@]3([H])[C@@](OC(C)(C)O3)([H])[C@@H](OCCCCCCCCCCCC)O2)C)=O
Molecular Formula
C30H47N2NaO7
Molecular Weight
570.69
References & Citations
[1]Shirumalla RK, et al. Pharmacodynamic and pharmacokinetic characterisation of RBx 7796: a novel 5-lipoxygenase inhibitor. Inflamm Res. 2008 Mar;57 (3) :135-43.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY401093 100 µg
TRAP alpha (SSR1) (NM_003144) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC740488-500 1x 500 µL
Topoisomerase I, MT (TOP1MT/488), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 